Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 1997

View Archived Issues

NIH seeks licensees for antispasmodic immunotoxin

Licenses offered for vasospasm therapy

NIH seeks licensees for method of treating allergies and HIV

Method of treating allergies and HIV offered for licensing

NIH seeks licensees for therapeutic/diagnostic HAV receptor

Antiviral nucleoside analogues available for licensing

CD40 ligands and MAbs offered for licensing

NIH seeks licensees for cancer vaccines

Licensees sought for recombinant laminin receptors

Transcriptional cofactor offered by NIH

DNA sequencing technology available for licensing

Medco's cardiovascular evaluation agent receives European approval

Correlation between asthma and IL-10

Gene vaccination shows potential against allergy

Phase I results with rhIL-4 receptor

Long-term use of recombinant IFN-gamma evaluated

Acorda and Elan to collaborate on spinal cord injury treatment

GalaGen's Diffistat-G advances through phase I

Role of IL-5 in asthma

IL-15 enhancement of neonatal defenses

Merck's Fosamax earns recommendation

Combination beta-agonist/corticosteroid therapy beneficial in asthma

Novo Nordisk's growth hormone now available in 67 countries

Efficacy of hydoxychloroquine in asthma

Review date set for Sonus ultrasound contrast agent

CytoTherapeutics and Cognetix collaborate on CNS R&D

Provir progresses through clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...